Crossmark

Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016

Crossref DOI link: https://doi.org/10.1186/s12936-021-03760-9

Published Online: 2021-05-25

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Diarra, Youssouf

Koné, Oumar

Sangaré, Lansana

Doumbia, Lassina

Haidara, Dade Bouye Ben

Diallo, Mouctar

Maiga, Ababacar

Sango, Hamadoun A.

Sidibé, Halidou

Mihigo, Jules

Nace, Douglas

Ljolje, Dragan

Talundzic, Eldin

Udhayakumar, Venkatachalam

Eckert, Erin

Woodfill, Celia J.

Moriarty, Leah F.

Lim, Pharath

Krogstad, Donald J.

Halsey, Eric S.

Lucchi, Naomi W.

Koita, Ousmane A. http://orcid.org/0000-0001-6535-3323
Funding

Funding for this research was provided by:

U.S President's Malaria Initiative (GHS-A-00-09-00003-00)

NIAID International center of Excellence in Malaria Research (ICEMR NIAID U19 AI 089696)
License Information

Text and Data Mining valid from 2021-05-25

Version of Record valid from 2021-05-25
More Information

Article History

Received: 20 September 2020

Accepted: 11 May 2021

First Online: 25 May 2021

Declarations

:

: All the authors have given their consent for publication.

: The authors have no competing interests.

Document is current

Any future updates will be listed below